These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 6838283

  • 1. Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ.
    Chah QT, Bertrix L, Bouzouita K, Lang J, Faucon G.
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):238-48. PubMed ID: 6838283
    [Abstract] [Full Text] [Related]

  • 2. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP, Alatienne M, Talmant JM, Ghyselinck N, Duchêne-Marullaz P.
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
    [Abstract] [Full Text] [Related]

  • 3. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B, Aupetit JF, Freysz M, Loufoua-Moundanga J, Faucon G, Timour Q.
    Arch Int Pharmacodyn Ther; 1996 Nov; 331(3):246-62. PubMed ID: 9124997
    [Abstract] [Full Text] [Related]

  • 4. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B, Aupetit JF, Freysz M, Faucon G, Timour Q.
    Pharmacotherapy; 1997 Nov; 17(4):737-45. PubMed ID: 9250551
    [Abstract] [Full Text] [Related]

  • 5. Effects of calcium channel blockers on sinoatrial conduction in the isolated and blood-perfused dog atrium.
    Kobayashi M, Shimotori M, Ogiwara Y, Chiba S.
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):72-82. PubMed ID: 3485962
    [Abstract] [Full Text] [Related]

  • 6. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q, Freysz M, Aupetit JF, Loufoua J, Frassati D, Faucon G.
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [Abstract] [Full Text] [Related]

  • 7. [Electrophysiologic effects of calcium channel blocking agents on the sinus node function in anesthetized dogs (author's transl)].
    Nakaya H, Kanno M, Kanda K, Oyama Y.
    Nihon Yakurigaku Zasshi; 1980 Nov; 76(8):697-707. PubMed ID: 6268495
    [Abstract] [Full Text] [Related]

  • 8. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE, Hamlin RL.
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [Abstract] [Full Text] [Related]

  • 9. Calcium-channel blocking agents.
    Leonard RG, Talbert RL.
    Clin Pharm; 1982 Jun; 1(1):17-33. PubMed ID: 6764159
    [Abstract] [Full Text] [Related]

  • 10. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A.
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [Abstract] [Full Text] [Related]

  • 11. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF, Bui-Xuan B, Kioueh I, Loufoua J, Frassati D, Timour Q.
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [Abstract] [Full Text] [Related]

  • 12. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A, Gout B, Bonhomme M, Landais L, Faivre JF, Linee P, Poyser RH, Ruffolo RR.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
    Nose I, Kataoka T, Honda Y, Yamada T, Ikeno A, Fukuya F, Minato H, Takeyama K, Hosoki K, Karasawa T.
    Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
    [Abstract] [Full Text] [Related]

  • 14. The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
    Lynch JJ, Montgomery DG, Lucchesi BR.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):340-5. PubMed ID: 3490565
    [Abstract] [Full Text] [Related]

  • 15. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV, Nedostup AV.
    Ter Arkh; 2006 Nov; 78(8):30-8. PubMed ID: 17078214
    [Abstract] [Full Text] [Related]

  • 16. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.
    Bova S, Cargnelli G, D'Amato E, Forti S, Yang Q, Trevisi L, Debetto P, Cima L, Luciani S, Padrini R.
    Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093
    [Abstract] [Full Text] [Related]

  • 17. Calcium channel blocking drugs.
    Johnston WE, Lowenstein E.
    Contemp Anesth Pract; 1983 Jan; 7():163-91. PubMed ID: 6309475
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of heart arrhythmias with calcium antagonists].
    Bender F.
    Z Kardiol; 1984 Jan; 73 Suppl 2():101-5. PubMed ID: 6084911
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M, Michelin MT, Tisne-Versailles J, Lamar JC.
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [Abstract] [Full Text] [Related]

  • 20. [Myocardial excitability under the influence of digitalis glycosides and anti-arrhythmia agent].
    Doenecke VP.
    Fortschr Med; 1977 Jan 20; 95(3):163-6. PubMed ID: 838426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.